Target intelligence / Profile preview

Protein inhibitor of activated STAT 1 (PIAS1)

Target
PIAS1
Molecular classification
E3 SUMO-protein ligase, Transcriptional coregulator, Scaffold attachment protein, Zinc finger protein, Other (nuclear protein with DNA- and protein-interaction domains)
01

Overview

Protein inhibitor of activated STAT 1 (PIAS1) is a nuclear protein functioning as an E3 SUMO-protein ligase, transcriptional coregulator, and scaffold attachment factor. PIAS1 selectively interacts with and inhibits STAT1 after cytokine stimulation by blocking its DNA-binding and gene activation capacity, thus acting as a negative regulator of interferon and cytokine signaling pathways. PIAS1 can also modulate the activities of other transcription factors, such as the androgen receptor, p53, SMAD proteins, and NF-κB, by repressing or enhancing their transcriptional functions depending on cellular context. Its E3 ligase activity promotes the sumoylation of target proteins, regulating their localization and function. PIAS1 is important for maintaining immune homeostasis and preventing excessive inflammatory responses, and it has been implicated in cellular responses relevant to cancer, inflammation, and infection. No selective drugs target PIAS1 clinically, but it is of research interest given its central role in several signaling pathways.

Other names
E3 SUMO-protein ligase PIAS1DDXBP1Gu-binding protein (GBP)GU/RH-IIZMIZ3DEAD/H box-binding protein 1RNA helicase II-binding proteinZinc finger, MIZ-type containing 3AR interacting proteinE3 SUMO-protein transferase PIAS1Protein inhibitor of activated STAT protein 1
02

Mechanism of action

Drugs or molecules that hypothetically target PIAS1 would inhibit or modulate its SUMO ligase or transcriptional repressor activity, leading to increased STAT1 (and potentially p53) activity or altered cytokine responsiveness

03

Biological functions

Negative regulation of STAT1-mediated gene activationRegulation of transcription (via DNA-binding inhibition or recruitment of co-regulators)Regulation of cytokine and interferon signalingProtein sumoylation (post-translational modification)Regulation of immune responseModulation of androgen receptor and other transcription factor activities
04

Disease associations

CancerInflammationInfection (innate and antiviral immune response, e.g. response to viral or bacterial infection)Possibly others (via broad regulation of immune and cytokine signaling networks)
05

Safety considerations

Potential for dysregulation of immune response (e.g., enhanced inflammation, autoimmunity, or impaired control of infection) due to altered STAT1 or NF-κB signalingEffects on multiple transcriptional regulators mean broad and pleiotropic impacts if targeted therapeutically
06

Interacting drugs

No approved drugs are currently known to target PIAS1 directly; it is a research target for modulation of STAT1 and possibly other pathways
07

Biomarkers

PIAS1 expression itself may be explored as a biomarker of cytokine signaling status, immune regulation, or disease state (especially in cancer or inflammatory diseases), but it is not an established or widely used biomarker

Beyond the preview

Go deeper on Protein inhibitor of activated STAT 1 (PIAS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein inhibitor of activated STAT 1 (PIAS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call